Abstract
BackgroundGLPG0634 is an orally-available, selective inhibitor of Janus kinase 1 (JAK1). JAKs are critical components in signaling pathways for a number of cytokines and growth factors, including those involved in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
